I have uncovered a previously unreported interview with Peter Cook:
http://tinyurl.com/qvhtyr
Selected highlights:
Peter Cook, Biota’s chief executive officer, told EP Vantage that Relenza royalties could triple in the current financial year and ultimately reach A$200m ($150m) on an annual basis
Aside from Roche and Glaxo as natural partners for CS-8958 (LANI), Mr Cook also highlighted other potential big pharma partners with the required expertise to succeed in this sector, such as Sanofi-Aventis, Novartis and AstraZeneca.
worth a read!
- Forums
- ASX - By Stock
- BTA
- peter cook: relenza could be worth a$200m p/a
peter cook: relenza could be worth a$200m p/a
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BTA (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
HAR
HARANGA RESOURCES LIMITED.
Peter Batten, MD
Peter Batten
MD
Previous Video
Next Video
SPONSORED BY The Market Online